Stock Screener App

Gratuito -

Drug Manufacturers - General

0.90

3.45% +0.03

Scilex Holding Company (SCLX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SCLX Giù? Forum Previsione

Scilex Holding Company Borsa (SCLX) Ultime notizie

Analysts Offer Predictions for Scilex Holding's Q2 2024 Earnings (NASDAQ:SCLX) - Defense World

Scilex Holding CEO Jaisim Shah buys $121k in company stock - Investing.com

Scilex Holding director Chun Jay buys $51.6k in company stock - Investing.com

Scilex Holding's executive chairperson buys $44k in company stock By Investing.com - Investing.com

Scilex Holding CFO buys $12,443 worth of company stock By Investing.com - Investing.com

Brokers Offer Predictions for Scilex Holding's Q2 2024 Earnings (NASDAQ:SCLX) - MarketBeat

Apollon Wealth Management LLC Sells 13900 Shares of Scilex Holding (NASDAQ:SCLX) - Defense World

What is Scilex Holding Company (SCLX) Stock Return on Shareholders' Capital? – Sete News - SETE News

Upward Trajectory: Scilex Holding Company (SCLX) Posts a Slidee, Closing at 0.80 – DWinneX - The Dwinnex

Scilex Holding Alerts Shareholders of Manipulative Trading Concerns - TipRanks.com - TipRanks

Scilex reaches settlement in patent lawsuit over Gloperba - Investing.com South Africa

Investing.com South Africa

Scilex wins court approval for Takeda settlement - MSN

Scilex wins court approval for Takeda pact (NASDAQ:SCLX) - Seeking Alpha

Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to ... - Yahoo Finance

What is the investor's view on Scilex Holding Company (SCLX)? – US Post News - US Post News

Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling ... - GlobeNewswire

Scilex (NASDAQ:SCLX) Shares Down 5.9% - Defense World

Analytical Overview: Scilex Holding Company (SCLX)'s Ratios Tell a Financial Story – DWinneX - The Dwinnex

Regional Business Director | Mid - Atlantic job with Scilex Holding Company | 2905507 - BioSpace

The Scilex Holding Company (SCLX) had a good session last reading, didn't it? – US Post News - US Post News

Regional Business Director | Mid - Atlantic job with Scilex Holding Company | 2905507 - BioSpace

Scilex (NASDAQ:SCLX) PT Lowered to $8.00 at HC Wainwright - Defense World

H.C. Wainwright cuts Scilex Holding shares target citing dilution impact - Investing.com

H.C. Wainwright cuts Scilex Holding shares target citing dilution impact - Investing.com India

Investing.com India

Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering

GlobeNewswire Inc.

Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering - GlobeNewswire

Scilex Holding Company Announces $15 Million Registered Direct Offering

GlobeNewswire Inc.

It's Down 33% But Scilex Holding Company (NASDAQ:SCLX) Could Be Riskier Than It Looks - Simply Wall St

Scilex reports growth in Q1 sales, plans to cut costs - Investing.com Canada

Investing.com Canada

Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool

GlobeNewswire Inc.

Scilex announces U.S. Bankruptcy Court extends lockup period on shares - TipRanks.com - TipRanks

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of ... - GlobeNewswire

Scilex Holding Ends Equity Purchase Deal with Yorkville - TipRanks.com - TipRanks

Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients

GlobeNewswire Inc.

Scilex announces agreement with Takeda to resolve patent infringement lawsuit - TipRanks.com - TipRanks

Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®

GlobeNewswire Inc.

Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to ... - GlobeNewswire

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and ... - GlobeNewswire

Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in ... - GlobeNewswire

Scilex reaches settlement in Sorrento bankruptcy case By Investing.com - Investing.com Australia

Investing.com Australia

Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.

GlobeNewswire Inc.

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement

GlobeNewswire Inc.

Scilex reaches settlement in Sorrento bankruptcy case By Investing.com - Investing.com

Scilex Holding Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Riding the Biotech Rollercoaster: Scilex's Stock Volatility Amid Sector Uncertainty - TipRanks.com - TipRanks

Scilex sets launch price of $595 per 150mL bottle of Gloperba - TipRanks.com - TipRanks

Scilex Holding Company Announces Closing of $10 Million Bought Deal Offering

GlobeNewswire Inc.

Scilex Holding Company Sets Launch Price of $595 per 150ml bottle of Gloperba®, its First and Only Liquid Oral ... - GlobeNewswire

Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information Updates

GlobeNewswire Inc.

Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline ... - Yahoo Finance

$44.03

0.18%

$44.98

0.22%

$48.67

0.31%

$28.64

0.97%

$312.47

0.71%

$102.57

0.12%

Apri su Yahoo | Apri su Google | Aperto in Finviz